Agitation,Psychomotor Clinical Trial
Official title:
Mindful Melody: Feasibility of Implementing Music Listening on an Inpatient Psychiatric Unit and Its Relation to the Use of As Needed Medications for Acute Agitation
NCT number | NCT04514432 |
Other study ID # | 1434789-1 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | August 16, 2018 |
Est. completion date | November 16, 2018 |
Verified date | August 2020 |
Source | State University of New York - Upstate Medical University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
In this quality improvement project, our objectives were to assess the feasibility and effectiveness of using music as an adjunct to or replacement of pharmacological interventions for patient agitation on an inpatient psychiatric unit. We hypothesized that music availability would help to reduce agitation and reduce the amount of as-needed medications used for cases of patient agitation.
Status | Completed |
Enrollment | 172 |
Est. completion date | November 16, 2018 |
Est. primary completion date | November 16, 2018 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Any patient 18 years or older admitted to the inpatient psychiatric unit Exclusion Criteria: - Patients who did not want to listen to music or be included in the project were excluded |
Country | Name | City | State |
---|---|---|---|
United States | Upstate University Hospital | Syracuse | New York |
Lead Sponsor | Collaborator |
---|---|
State University of New York - Upstate Medical University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The number of medications used for agitation | The number of different types of medications used for agitation was quantified using pharmacy records | 5/18/2018 until 11/13/2018 | |
Secondary | Scales administered to nursing staff | Scales administered to nursing to determine ease of implementation and effect on the psychiatric unit milieu | 5/18/2018 until 11/13/2018 | |
Secondary | Scales administered to patients | Scales administered to patients to assess the extent of the calming effect of listening to music | 5/18/2018 until 11/13/2018 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT03110900 -
Inhaled Loxapine vs Intramuscular (IM) Haloperidol + Lorazepam for Agitation
|
Phase 4 | |
Completed |
NCT05272501 -
CAlming Touch for People With Agitation or Other Behavioural Symptoms of DEMentia - A Randomized Feasibility Trial
|
N/A | |
Completed |
NCT06041646 -
Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder
|
Phase 4 | |
Completed |
NCT06217146 -
A Medical Cannabis Oil for Treatment of Agitation and Disruptive Behaviors in Subjects With Dementia.
|
N/A | |
Recruiting |
NCT05543681 -
IGC-AD1 Trial on Agitation in Dementia Due to Alzheimer's
|
Phase 2 | |
Recruiting |
NCT03513549 -
Observational Study Evaluating the Safety of ADASUVE® in Agitation Associated With Schizophrenia or Bipolar I Disorder
|
||
Active, not recruiting |
NCT05658510 -
Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)
|
Phase 3 | |
Not yet recruiting |
NCT05612711 -
Dronabinol for Agitation in Dementia Crossover Trial
|
Phase 2 | |
Recruiting |
NCT04957238 -
Physical Restraints in Intensive Care Unit Patients
|
N/A | |
Completed |
NCT03208452 -
The Effect of Intraoperative Magnesium Sulfate Infusion on the Occurrence of Emergence Agitation
|
Phase 4 | |
Terminated |
NCT03899506 -
Olanzapine Versus Midazolam for Agitation
|
||
Completed |
NCT03211897 -
Olanzapine, Haloperidol, Ziprasidone, Midazolam for Acute Undifferentiated Agitation
|
N/A | |
Recruiting |
NCT05783505 -
A Multicomponent Intervention Program to Prevent and Reduce ICU Agitation and Physical Restraint Use
|
N/A | |
Completed |
NCT04053426 -
Agitation Follow up After Introduction of a New Patient Care Algorithm
|
||
Completed |
NCT03226522 -
Addressing Dementia Via Agitation-Centered Evaluation
|
Phase 2/Phase 3 | |
Recruiting |
NCT03926520 -
Electroconvulsive Therapy (ECT) for Agitation in Dementia (AD)
|
N/A | |
Recruiting |
NCT04075435 -
Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Mild Cognitive Impairment or Alzheimer's Dementia
|
Early Phase 1 | |
Completed |
NCT04276883 -
Dexmedetomidine in the Treatment of Agitation Associated With Bipolar Disorder
|
Phase 3 | |
Completed |
NCT04797715 -
Assessing Clinical Outcomes in Alzheimer's Disease Agitation
|
Phase 3 | |
Completed |
NCT04251910 -
Sub-Lingual Dexmedetomidine in Agitation Associated With Dementia
|
Phase 1/Phase 2 |